Works matching IS 1082801X AND DT 2005 AND VI 40 AND IP 9
Results: 19
Medication safety and reliability: a collection of the latest drug safety news, notices, labeling changes, and drug availability issues. Advisory committee recommends continued marketing of beta2-agonists, black-box warning for formoterol.
- Published in:
- 2005
- Publication type:
- Journal Article
Letter to the editor.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
News capsules: what's new in drug research and managed care pharmacy. Bisphosphonate maintains BMD gains achieved with parathyroid hormone.
- Published in:
- 2005
- Publication type:
- Journal Article
Cost-effectiveness of 4 empiric antimicrobial regimens in patients with community-acquired pneumonia.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
FDA drug approvals. FDA actions in brief.
- Published in:
- 2005
- Publication type:
- Journal Article
Focus on... muraglitazar: a dual peroxisome proliferator-activated receptor agonist.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
Epilepsy and migraine.
- Published in:
- 2005
- Publication type:
- Other
Selected literature.
- Published in:
- 2005
- Publication type:
- Bibliography
Safety labeling updates & new warnings.
- Published in:
- Formulary, 2005, v. 40, n. 9, p. 311
- Publication type:
- Article
Advisory committee recommends continued marketing of beta<sub>2</sub>-agonists, black-box warning for formoterol.
- Published in:
- Formulary, 2005, v. 40, n. 9, p. 311
- Publication type:
- Article
Drug and Formulary Trends.
- Published in:
- 2005
- Publication type:
- Other
Bisphosphonate maintains BMD gains achieved with parathyroid hormone.
- Published in:
- Formulary, 2005, v. 40, n. 9, p. 305
- Publication type:
- Article
Letter to the Editor.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Cost-effectiveness of 4 empiric antimicrobial regimens in patients with community-acquired pneumonia.
- Published in:
- Formulary, 2005, v. 40, n. 9, p. 298
- By:
- Publication type:
- Article
First-time generic approvals.
- Published in:
- Formulary, 2005, v. 40, n. 9, p. 297
- Publication type:
- Article
New formulations.
- Published in:
- Formulary, 2005, v. 40, n. 9, p. 296
- Publication type:
- Article
New indications.
- Published in:
- Formulary, 2005, v. 40, n. 9, p. 296
- Publication type:
- Article
FDA actions in brief.
- Published in:
- Formulary, 2005, v. 40, n. 9, p. 296
- Publication type:
- Article
Muraglitazar.
- Published in:
- Formulary, 2005, v. 40, n. 9, p. 285
- By:
- Publication type:
- Article